Skip to content
Download our PinkPharm App now to enjoy exclusive discounts!
Download our PinkPharm App now to enjoy exclusive discounts!



Notify me when back in stock

Description :

UrgoTul®  is a non-adhesive, non-occlusive contact layer, composed of a polyester mesh impregnated with Lipido-Colloid Technology (TLC). TLC is composed of hydrocolloid particles (carboxymethylcellulose), paraffin oil, petrolatum and polymers. The TLC (Lipido-Colloid Technology) is an exclusive patented innovation from Urgo.


UrgoTul is indicated for  :

  • Acute wounds (burns, dermal abrasions, traumatic wounds, postoperative wounds), chronic wounds (pressure ulcers, diabetic foot ulcers) at the granulation and epithelialisation stage.
  • Non to low exuding wounds
  • Non infected
  • Can be combined with a secondary dressing
  • Can be used in cavity wounds


In contact with wound exudate, the hydrocolloid particles interact with the petroleum jelly component to form a lipido-colloid interface. The interface creates a moist environment ideal for wound healing.

Providing harm free care :

  • No pain at dressing changes 1
  • Will not damage newly formed tissue 2,3,4

Providing a nurturing environment for healing

  • Promotes wound healing through stimulation of key cells proliferation 5,6
  • Creates a moist wound healing environment 2,3,7,8
  • Non-adherence to the wound bed 9
  • Protects the surrounding skin 3,9,10
  • Does not dry out: can be left in place for up to 7 days



1.Meaume et al. The importance of pain reduction through dressing selection in routine wound management: the MAPP study, Journal of Wound Care, 2004, Vol 13, No 10, 409-413.

2.M. Le Berre, Y. Lurton et al., Pansements imprégnés : tulles/ interfaces. Poster, CPC 2005, Paris.

3.Parpex P. et al. Management of venous leg ulcers with Cellosorb® Micro-adherent dressing: results of a multi-centre clinical trial. Phlebologie 2010; 63: 76-82.

4.Meaume S. Urgotul®: a novel non-adherent lipidocolloid dressing. British Journal of Nursing. 2002, Vol 11, N°16.

5.Bernard FX. , Barrault C. et al., Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipidocolloïd dressing. Journal of Wound Care, May 2005; 14 (5) : 215-220. (Study conducted on Urgotul).

  1. FX. Bernard, F. Juchaux et al., Effets d’un pansement lipido-colloïde sur la production de matrice extracellulaire. Journal des Plaies et Cicatrisations, 2007. (Study conducted on Urgotul).
  2. Report No. RE/DA/2013-164/LAP.
  3. Benbow M. A clinical evaluation of Urgotul® to treat acute and chronic wounds. British Journal of Nursing. 2004. Vol 13, N°2: 105-109.
  4. White R. Supporting evidence - based practice: a clinical review of TLC technology, J Wound Care 2015.
  5. Meaume S. et al. Optimizing wound care with a new lipido-colloid dressing (Urgotul Duo). British Journal of Nursing 2007; 16(6).